Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: BJU Int. 2011 Sep 27;109(11):1676–1684. doi: 10.1111/j.1464-410X.2011.10593.x

Table 2.

Characteristics of users by antihypertensive class, and overlap among classes.

Beta blockers
(N=504)
ACE inhibitors
(N=547)
Calcium channel
blockers (N=330)
Angiotensin receptor
blockers (N=100)
Thiazide diuretics
(N=451)
Loop diuretics
(N=126)
Mean age (SE) 59.7 (0.5) 58.4 (0.5) 59.4 (0.6) 62.2 (1.0) 57.6 (0.5) 62.6 (0.9)
% 65+ 35.5 29.3 36.4 40.0 28.4 44.4
% women 60.5 59.1 62.7 64.0 71.6 67.5
% using beta blockers 100.0 32.4 36.1 40.0 33.0 54.8
% using ACE inhibitors 35.1 100.0 36.4 7.0 35.7 51.6
% using CCBs 23.6 21.9 100.0 35.0 25.1 34.1
% using ARBs 7.9 1.3 10.6 100.0 10.6 13.5
% using thiazide diuretics 29.6 29.4 34.2 48.0 100.0 6.4
% using loop diuretics 13.7 11.9 13.0 17.0 1.8 100.0
% using only this class 31.6 36.8 27.6 19.0 27.5 13.5
% using 2 classes 36.5 36.6 29.7 37.0 45.7 31.0
% using 3+ classes 31.9 26.7 42.7 44.0 26.8 55.6
*

Percents shown are column percents and may not sum to 100.0 due to rounding.

ACE=angiotensin-converting enzyme, CCB=calcium channel blocker, ARB=angiotensin receptor blocker.